Spasmoanalgesic properties of 4-propionyl-4--(3-chlorphenyl)-1-[3-(4-methylpiperazine)-propyl (-piperidine)] trihydrochloride.
The paper describes the biological activity and pharmacological properties, particularly the spasmolytic and analgesis effects, of newly synthesized 4-propionyl-4-3(3-chlorphenyl)-1-[3-(4-methyl-piperazine)-propyl]-piperidine trihydrochloride (denoted S10).
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D051379:Mice; D008815:Mice, Inbred Strains; D010276:Parasympatholytics / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D010880:Piperidines / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D011919:Rats, Inbred Strains; D013268:Stimulation, Chemical; D014599:Uterus / Q000187:drug effects
D000700:Analgesics; D010276:Parasympatholytics; D010879:Piperazines; D010880:Piperidines